French journal calls for domperidone to be withdrawnBMJ 2014; 348 doi: https://doi.org/10.1136/bmj.g1722 (Published 24 February 2014) Cite this as: BMJ 2014;348:g1722
- Paul Benkimoun
The independent French medical journal Prescrire has called for the drug domperidone to be withdrawn after a study it conducted estimated that the drug caused about 25 to 120 premature deaths in 2012 in France alone.
The European Medicines Agency (EMA) is due to issue an opinion on domperidone in March, but the journal believes the agency will recommend lower dosages and shorter treatment. This is not enough, believes Prescrire. “It is high time the European health authorities withdrew this drug from the market,” it said in a statement.
It added: “These measures [proposed by the …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial